| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.043 | 0.4 |